Integrated Core Strategies (US) LLC 13D/13G Filings for Rigel Pharmaceuticals, Inc. (RIGL)

Integrated Core Strategies (US) LLC 13D and 13G filings for Rigel Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:39 pm
Sale
2020-12-3113GRigel Pharmaceuticals, Inc.
RIGL
Integrated Core Strategies (US) LLC102,848
0.600%
-749,694decrease
(-87.94%)
Filing